Breast Implants Market Overview
The global breast implants market is expected to witness considerable growth during the forecast period, owing to increasing prevalence of breast cancer, rising number of breast augmentation procedures, increase in disposable income, and growing appearance consciousness among customers.
On the basis of product, the breast implants market is categorized into silicone implants and saline implants. Silicone implants dominate the market, as these implants have less complications as compared to saline implants. Moreover, increasing number of silicone implants-based breast augmentation procedures is also contributing toward the leading position of this product category.
Based on shape, the breast implants market is bifurcated into round and anatomical. Of these, round-shaped implants held larger share of the market during the historical period. However, the anatomical-shaped implants category is projected to witness notable growth during the forecast period. The growth is mainly driven by their appropriate design, which makes them natural in appearance, and ease in breast enhancement.
Based on application, the market is classified into cosmetic surgery and reconstructive surgery. There has been a significant increase in the use of these implants in the cosmetic surgeries. Further, the rising number of cosmetic procedures has spurred the demand for such products, which is fueling the growth of breast implants industry.
The breast implants market is categorized into hospitals, ASCs, and aesthetic clinics on the basis of end user. During the historical period, the hospitals category generated the highest revenue in the market and expected to maintain this trend during the forecast period. Increasing prevalence of breast cancer cases along with the rising number of breast augmentation procedures are prime factors supporting the growth of this category.
Geographically, North America, followed by Europe, held the largest share in the breast implants market in 2017. The North American market is primarily driven by increasing demand of these implants, presence of key established players, favorable reimbursement policies, and increasing prevalence of breast cancer across the region.
The breast implants market in Asia-Pacific is expected to grow at the fastest pace during the forecast period. This is attributed to the rising prevalence of breast cancer, increasing healthcare expenditure, growing medical tourism, increasing awareness about breast cancer and its treatment, and rising focus of market players toward emerging countries.
Breast Implants Market Dynamics
Increasing prevalence of breast cancer, rising number of breast augmentation procedures, increasing disposable income, and rising appearance consciousness are some of the major factors contributing to the growth of the breast implants market. According to the report “Breast Cancer Facts and Figures 2017–2018”, published by the American Cancer Society (ACS), it was estimated that 252,710 and 2,470 new cases of invasive breast cancer were diagnosed among women and men, respectively, in 2017 in the U.S. Moreover, according to the International Society of Aesthetic Plastic Surgery (ISAPS), in 2016, total 1,449,337 breast augmentation procedures were performed with silicone implants, and 61,780 procedures with saline implants, globally.
Stringent regulatory requirement and high cost of these implants are major factors hindering the growth of the market. Breast implants are regulated as Class III medical devices, which require to follow stringent and extensive regulatory standards implemented by the Unites States Food and Drug Administration (USFDA) and other regulatory bodies in the U.S. and other countries for their approval. The lengthy process of clinical development and approvals is also expected to restrict the growth of the breast implants market.
Breast Implants Market – Competitive Landscape
Key players in the breast implants market are seeking approval and acquiring other players to introduce new implants in order to increase their business and market share. For instance, in June 2017, Allergan plc (Allergan) acquired Keller Medical Inc. (Keller), a medical device company that developed Keller Funnel, a surgical device used in conjunction with breast implants. The acquisition helped Allergan to expand its plastic surgery related product portfolio.
Moreover, in March 2017, Allergan received USFDA approval for NATRELLE INSPIRA SoftTouch breast implant. The implant is used in breast reconstruction augmentation and revision surgeries.
Some other players present in the global breast implants market include Mentor Worldwide LLC, Establishments Lab S.A., POLYTECH Health and Aesthetics GmbH, Sientra Inc., GC Aesthetics, CEREPLAS, Laboratories Arion, and Guangzhou Wanhe Plastic Materials Co., Ltd.